Fujifilm and HORIBA Co-Develop High-Sensitivity Inline Raman Measurement System to Advance Biopharmaceutical Manufacturing FUJIFILM Corporation and HORIBA, Ltd. have announced the joint development of a high-sensitivity inline Raman measurement system…
Guided Therapeutics Submits Positive LuViva Clinical Trial Results to FDA, Demonstrating Enhanced Detection of Precancerous Cervical Disease Guided Therapeutics, Inc., a medical technology company focused on improving cervical cancer detection…
Emmecell Secures Strategic Financing to Advance Magnetic Cell Delivery Technology for Ophthalmic Diseases Emmecell, a clinical-stage biotechnology company focused on developing innovative magnetic cell delivery technologies for the treatment of…
Simulations Plus Agrees to $375 Million Acquisition by Altaris, Signaling New Chapter in AI-Driven Drug Development Simulations Plus, Inc., a recognized leader in model-informed drug development and artificial intelligence-enabled pharmaceutical…
Pelago Bioscience Expands Drug Discovery Capabilities Through Acquisition of RG Discovery Pelago Bioscience, a leading contract research organization (CRO) specializing in cell-based target engagement technologies, has announced the acquisition of…
Takeda Presents New Phase 3 Data Showing Oveporexton Improves Daily Functioning, Cognition, and Sleep in Narcolepsy Type 1 Takeda has unveiled additional findings from its pivotal Phase 3 clinical development…
OM Pharma Presents Preliminary REACH Study Findings Demonstrating Real-World Benefits of Broncho-Vaxom® in Preventing Recurrent Respiratory Tract Infections OM Pharma has announced the presentation of preliminary results from its landmark…
Incyte Reports Positive Phase 3 frontMIND Results Showing Tafasitamab and Lenalidomide Plus R-CHOP Improves Outcomes in High-Risk DLBCL and HGBL Incyte has announced positive results from its pivotal Phase 3…
Biocytogen’s Boston Research Facility Earns AAALAC International Full Accreditation, Reinforcing Commitment to Scientific Excellence and Animal Welfare Biocytogen has announced a significant achievement for its U.S. research operations, revealing that…
Sumitomo Pharma America Highlights New Clinical and Translational Research for Nuvisertib and Enzomenib at EHA 2026 Sumitomo Pharma America, Inc. (SMPA) has unveiled new clinical and translational research findings at…
Cellares Secures Additional $50 Million Investment, Expanding Series D Financing to $327 Million to Accelerate Global Cell Therapy Manufacturing Network Cellares, the world’s first Integrated Development and Manufacturing Organization (IDMO)…
Arialys Therapeutics Advances ART5803 Development With Phase 2 Progress and FDA Clearance for New Clinical Study in Anti-NMDA Receptor Encephalitis Arialys Therapeutics, a clinical-stage biotechnology company focused on developing precision…